Novel antimony-based antimicrobial drug targets membranes of Gram-positive and Gram-negative bacterial pathogens.
Tarosha SalpadoruKevin E PinksJacob A LiebermanKaitlyn CottonKaren L WozniakNikolay GerasimchukMarianna A PatrauchanPublished in: Microbiology spectrum (2024)
ACO in combating both Gram-positive and Gram-negative bacterial pathogens while enhancing the efficacy of existing antibiotics.